with a microsequenator (model 890C ; Beckman Instruments, Inc.) according to the principles first described by Edman and Begg (20) and as previously described (19) .
Synthesis of Human Vimentin Peptides . Peptide copies from two regions of human vimentin (21) containing the tripeptide sequence Arg-Leu-Arg were synthesized by the solid phase method of Merrifield (22) , as described (23) . The synthetic peptides were cleaved, deblocked with hydrofluoric acid, and purified by gel filtration on a column of Sephadex G10 (Pharmacia Fine Chemicals, Uppsala, Sweden) as previously described (19) . The purity and composition ofthe peptide were assured by HPLC on Ultrasphere ODS2 (Whatman Inc ., Clifton, NJ), by quantitative amino acid analysis, and by automated Edman degradation to the penultimate amino acid residue (19) . The peptides were synthesized with a COOH-terminal cysteine to enable coupling to a carrier molecule using a bifunctional crosslinking reagent . The peptide copies of regions of human vimentin are designated SV(63-73)C and SV(178-188)C . The peptides SMl(1-12)C, SMl(1-26)C, SM1(19-32)C, and SMl(23-26)C were synthesized in a previous study (12) .
Indirect Immunofluorescence Assays. Rat mesangial cells and rat skin fibroblasts (CRL 1213; American Type Culture Collection, Rockville, MD) were grown for 2 d on cover slips in Eagle's MEM, supplemented with 20°Io FCS, with 5% C02 in the atmosphere at 37°C . The cells on the cover slips were rinsed with PBS and then fixed with 1 % paraformaldehyde for 5 min. The cover slips were washed in PBS, incubated with purified crossreactive antibodies at a dilution of 1 :4 in PBS for 30 min at room temperature, washed thoroughly with PBS, and incubated with fluorescein-conjugated goat anti-rabbit IgG (CooperBiomedical, Inc ., Malvern, PA) at a dilution of 1 :40 in PBS for 30 min at room temperature . After washing again, the cover slips were mounted in gelvatol on microscope slides and examined with a fluorescence microscope (Carl Zeiss, Inc., Thornwood, NY) . Indirect immunofluorescence tests with frozen sections (4 um thick) of rat and normal human renal cortex were performed as previously described (1, 24) . The specificity of the crossreactive antibodies was tested by immunofluorescence inhibition assays . The immune serum 8652 was preincubated at a dilution of 1 :4 in PBS for 30 min at 37°C with synthetic peptides at a concentration of 100 pM or with 0 .5 mg/ml of vimentin or desmin, and then used in the indirect immunofluorescence tests as described (1, 24) .
Results
Previous studies have shown that antisera raised against synthetic peptides of the NH 2 terminus of type 1 M protein react with human, mouse, and rat glomeruli (12) . The crossreactive epitope was localized to a tetrapeptide sequence Ile-Arg-LeuArg at positions [23] [24] [25] [26] from the NH2-terminal end of the mature type 1 M protein molecule (12) . The purpose of the present study was to identify the autoimmune target in host tissues .
Crossreactivity with Cultured Mesangial Cells and Fibroblasts . Since the binding pattern of the crossreactive antibodies in the glomeruli suggested mesangial cell distribution of the antigens, we isolated rat glomeruli and used them to obtain primary cultures of mesangial cells (14) . The cells were cultured on cover slips and used in indirect immunofluorescence tests . Antibodies from the strongest crossreactive antiserum 8652 (ELISA titer against Ile, Arg, Leu, Arg, 1 :3,200) raised against SM1(1-19) (23-26)C were affinity purified over a column of Affi-Gel 10 to which the synthetic peptide had been covalently linked (12) . The purified antibodies (ELISA titer against Ile, Arg, Leu, Arg, 1 :1,600) reacted with the mesangial cells in a reticular pattern (Fig . 1 A) . The reaction was totally inhibited by preincubation of the antibodies with SMl(1-26)C (Fig . 1 B) . Similar results were obtained with antibodies (ELISA titer against Ile, Arg, Leu, Arg, 1 :800) purified over an Ile-Arg-Leu-Arg-Cys-Affi-Gel 10 column (data not shown), suggesting that antibodies directed against the COOH- terminal region of the peptide were responsible for the crossreactions . Incubation ofthe crossreactive antibodies with rat skin fibroblasts showed a similar fibrillar staining pattern ( Fig. 1 C) ; the reaction was also totally inhibited by preincubation of the antiserum with SM1(1-26)C (Fig. 1 D) . The patterns of antibody binding in the two cell types suggested a reaction with a class ofprotein fibrils known as intermediate filaments or 10-nm filaments.
Identification of CrossreactioeAntigen .
To identify the crossreactive antigen, cultured mesangial cells were extracted with a buffer containing 8 Murea, 100 mM Tris HCl, 2 M NaCl, 0.1% a-ME, pH 7 .0, and the extracted proteins were analyzed by SDS-PAGE (Fig. 2, lane 1) . For ease of comparison, the two proteins, vimentin and desmin, composing the intermediate filaments ofglomerular mesangial cells (25) , were purchased commercially (see Materials and Methods) and applied to the same 8% SDS-PAGE (Fig. 2, lanes 2 and 3, respectively) . Several protein bands were detected in the mesangial cell extract (Fig. 2, lane 1) . Three of these reacted with anti-M protein peptide antibodies purified from rabbit antiserum 8652 ; they migrated as 56-, 52-, and 49-kD polypeptides (Fig. 2, lane 4) . Furthermore, the antibodies reacted with purified vimentin but not desmin ( the mesangial extract was completely blocked by absorption of antiserum 8652 with whole M1 but not M24 streptococci (data not shown), indicating the accessibility of the crossreactive epitope on intact Ml protein.
These results suggested that the 56-kD protein is vimentin and the lower molecular weight proteins are degradation products of this protein. It should be mentioned that the purchased vimentin was purified from bovine lens and the desmin was purified from chicken stomach, whereas the proteins in the present study were extracted from rat mesangial cells. The fact that the proteins originate from different species and that the extracted proteins were applied to the gel in 4 M urea, whereas the purified proteins were applied in 0.3 M urea, may account for the slight difference in the apparent molecular weights of bovine vimentin and the 56-kD protein.
To determine whether vimentin could inhibit the renal glomerular crossreactivity of antiserum 8652, immunofluorescence inhibition tests were performed. Bovine vimentin and the synthetic peptide SMl(1-26)C completely inhibited renal glomerular fluorescence, whereas chicken desmin had no inhibitory effect (Table I) . Moreover, the crossreactive antibodies were completely absorbed by MI but not M24 streptococcal cells (Table I ). These results indicated that the crossreactive antibodies bind to the native M protein molecule and to similar determinants of authentic vimentin and the glomerular crossreactive protein(s), providing additional evidence that the crossreactive antigen is vimentin. To further confirm this notion, we investigated whether monoclonal and polyclonal antibodies against human vimentin would react with the crossreactive proteins extracted from mesangial cells. Both types of antibodies reacted strongly in Western blots with the three crossreactive proteins extracted from rat mesangial cells (Fig.  3, lanes 2 and 3) , whereas an mAb against human desmin did not react with any of the extracted proteins (Fig. 3, lane 4) . The mAbs against vimentin reacted with renal glomeruli and mesangial cells in a pattern identical to that of the crossreactive antisera raised against the type 1 M protein peptide (not shown) . The reactivity of the mAbs against vimentin with all three crossreactive proteins indicate that the 56-kD protein most likely is vimentin and the two smaller proteins are degradation products of this protein.
Localization of the Crossreactiae Epitope(s) of Vimentin . Since the glomerular crossreactive epitope of type 1 M protein previously was shown to be specified by the tetrapeptide sequence Ile-Arg-Leu-Arg (12), we searched for homologous amino acid sequences in human vimentin (21) . We found that vimentin contains the sequence Arg-Leu-Arg, both at position 68-70 and at 183-185. To determine whether these sequences flanked by adjacent sequences of Vimentin might be recognized by the crossreactive antibodies, we synthesized two 11-residue peptides encompassing the two Arg-Leu-Arg sequences and tested their crossreactivity in immunofluorescence and Western blot inhibition assays . The synthetic peptides, designated SV(63-73)C and SV(178-188)C, both totally inhibited the glomerular crossreactivity of antiserum 8652 (Table II) . As previously reported (12) , and as shown again in Table II for comparison, peptides of MI protein containing the sequence Ile-Arg-Leu-Arg, but not those lacking this sequence, similarly blocked immunofluorescence.
These results were confirmed in Western blot and quantitative ELISA inhibition tests . Both synthetic peptides ofvimentin encompassing the sequence Arg-Leu-Arg blocked the reaction of antiserum 8652 in Western blots with the urea-extracted proteins ofmesangial cells as well as with authentic bovine vimentin (data not shown) . In ELISA inhibition tests of antiserum 8652 against the Mprotein peptide SMl(19- 32)C, both vimentin peptides were inhibitory in a dose-related fashion (Fig. 4) . On a molar basis, however, the vimentin peptide SV(63-73)C was -100-fold more inhibitory then SV(178-188)C and was equal in potency to the M protein pentapeptide Ile-Arg-Leu-Arg-Cys. We chose peptide SMl(19-32)C as the ELISA antigen Each synthetic peptide was tested at a concentration of 100 uM, except for IRLR_C, which was tested at a concentration of 5 mM . The sequence of the NH2-terminal region of type 1 M protein was confirmed in a previous study (13) . The human vimentin sequence was derived from a cDNA clone (21) . The single letter code for amino acid residues is used to conserve space and for ease of comparison . Underscored cysteine residues were added for the purpose of coupling to a carrier . These data have been reported previously (12) and are shown again here for comparison . (28) . The subunit is composed of a central a helix-rich (rod) domain of -311-314 amino acid residues, and N112-terminal (head) and COOH-terminal (tail) domains of variable size and chemical character. Generally, neither of the latter assume an a-helical conformation . The a-helical domains of these proteins give rise to a coiled-coil fibril with the amino acid sequences following a seven-residue periodicity of the form a-b-c-d-e-f-g, in which residues at positions a and d are usually apolar and those at g are usually polar. This repeating pattern of residues gives rise to a coiled-coil fibril with the apolar residues buried along its axis .
Each of the M proteins of group A streptococci studied thus far shows a similar seven-residue periodicity of polar and apolar amino acids (13, 29, 30) . In addition, it has been shown that the M proteins protrude as a-helical coiled-coil fibrils from the surface of virulent strains of streptococci (9) . These fibrils render the organisms resistant to recognition and ingestion by phagocytes of the nonimmune host (8, 10) . The similarity ofthe M protein a-helical structure to that ofmammalian coiled-coil proteins, such as myosin, keratin, vimentin, desmin, and fibrinogen, was pointed out earlier by Manjula et al. (30) . It should not be surprising, therefore, that the only M protein crossreactive tissue proteins identified thus far belong to this group of proteins .
Krisher and Cunningham (5) first described a crossreaction of mAbs to type 5 streptococci with cardiac myosin . Later it was shown that types 5, 6, and 19 M proteins contain epitopes that are shared with cardiac myosin (3, 4) . Most recently, we identified a renal glomerular crossreactive tetrapeptide sequence, Ile-Arg-Leu-Arg, in the NH2 terminus of type 1 M protein (12) . Because the staining pattern of the crossreactive antibodies suggested a mesangial cell distribution ofthe antigen in the glomeruli, we undertook the present study of the crossreactivity of these antibodies with cultured mesangial cells.
The staining pattern obtained with mesangial cells and fibroblasts suggested that intermediate filaments were involved in the crossreactions . Since only two intermediate filaments, desmin and vimentin, had been found in glomerular mesangial cells and fibroblasts (25, 26, 31) , we focused our investigations on these two proteins and found vimentin to be the autoimmune target . The evidence that vimentin is the target is as follows: (a) the M protein peptide crossreactive antibodies reacted with authentic vimentin but not desmin in Western blots; (b) vimentin, but not desmin, inhibited the crossreactions both in immunofluorescence and Western blot tests; (c) monoclonal and polyclonal antibodies raised against human vimentin reacted with the putative vimentin extracted from rat mesangial cells in the same pattern as that obtained with the crossreactive antiserum; (d) the mAbs against human vimentin reacted with glomeruli and mesangial cells in a pattern identical to that of the crossreactive antibodies; and (e) synthetic peptides copying vimentin sequences encompassing the tripeptide Arg-Leu-Arg inhibited the reaction ofthe Ml protein peptide antiserum with mesangial cells and extracted vimentin .
Extensive homologies between the sequences of vimentins ofdifferent species have been reported . The sequence of human vimentin (21) is 98% homologous to that of Syrian hamster vimentin (32) , and the hamster sequence exhibits 80% homology with that of chicken vimentin (33) . The high degree of homology between the two mammalian vimentin sequences suggests that the sequence of rat vimentin is similarly homologous . It is probable that the 56-kD protein, which is similar in molecular mass to that of human vimentin, represents rat vimentin and the lower molecular weight proteins stained with the monoclonal antivimentin antibody represent degradation products of this protein. Such degradation of vimentin had been noticed in earlier studies by Franke et al. (34) .
Because the crossreactive epitope of type 1 M protein was previously shown to be specified by the tetrapeptide sequence Ile-Arg-Leu-Arg (12), we searched for homologies in the amino acid sequence of human vimentin (21) . Two regions were found containing the tripeptide sequence Arg-Leu-Arg at positions 68-70 and 183-185. Region 67-70 is part of the random-coil NH2-terminal (head) domain, whereas region 182-185 lies in the a-helical (rod) domain of the vimentin sequence . By comparison, the crossreactive epitope Ile-Arg-Leu-Arg at positions 23-26 of type 1 M protein is predicted to be located at the beginning ofthe a-helical coiled-coil structure ofthe molecule . Taking into account the primary and secondary structural features ofthe potentially crossreactive epitopes in human vimentin and type 1 M protein, one might predict that the sequence Arg-Leu-Arg at positions 183-185 in the a-helical part of vimentin would be the major binding site of the crossreactive antibodies . However, the two 11-residue synthetic peptides of vimentin encompassing each of the Arg-Leu-Arg sequences and adjacent amino acids exhibited markedly different potencies in their inhibitory activities against the crossreactive antiserum 8652; the peptide SV(63-73)C was -100-fold more inhibitory than SV(178-188)C . We cannot conclude from these results which of these sites is more accessible in the intact vimentin molecule because tertiary structural constraints undoubtedly play a role (35) .
In this regard, the crossreactive antibodies did not react with chicken desmin, although this protein contains an amino acid sequence, Arg-Leu-Arg, at positions 132-135 (36) . Either this sequence is inaccessible in the intact molecule or it does not by itself represent an epitope that is recognized by antiserum 8652; sequence identity of short peptides does not ensure similarity of structural shape (35) .
In summary, we have demonstrated that antibodies directed against the epitope Ile-Arg-Leu-Arg of the nephritogenic type 1 M protein react with the intermediate filament protein vimentin of renal glomerular mesangial cells . The identification of the crossreactive antigen is one important step toward establishing a connection between autoimmune reactions and the pathogenesis of acute poststreptococcal nephritis . Further studies are in progress to assess the accessibility of mesangial cell vimentin to the crossreactive antibodies and to determine the role of autoimmune reactions to streptococcal M proteins in the generation of acute and chronic inflammatory diseases .
Summary
The crossreactivity of antibodies against a renal autoimmune epitope of Streptococcus pyogenes M protein with glomerular mesangial cells was investigated . The antibodies directed against the amino acid sequence Ile-Arg-Leu-Arg of the nephritogenic type 1 M protein reacted in a fibrillar pattern with mesangial cells cultured from isolated glomeruli . In Western blots of urea-extracted mesangial proteins, the antibodies reacted with a 56-kD protein . Monoclonal and polyclonal antibodies identified the 56-kD mesangial protein as vimentin . Two synthetic peptides of human vimentin containing the sequence Arg-Leu-Arg reacted with the autoimmune antibodies raised against a streptococcal M protein peptide. These results provide evidence that the intermediate filament protein vimentin shares autoimmune epitopes with streptococcal M protein .
